Compare SGMO & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGMO | CMTL |
|---|---|---|
| Founded | 1995 | 1967 |
| Country | United States | United States |
| Employees | N/A | 1385 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 162.1M |
| IPO Year | 2000 | 2024 |
| Metric | SGMO | CMTL |
|---|---|---|
| Price | $0.33 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.00 | $6.00 |
| AVG Volume (30 Days) | ★ 4.5M | 332.3K |
| Earning Date | 05-11-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $36,567,000.00 | ★ $499,528,000.00 |
| Revenue This Year | $4.79 | N/A |
| Revenue Next Year | N/A | $4.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.32 | $1.19 |
| 52 Week High | $0.88 | $6.21 |
| Indicator | SGMO | CMTL |
|---|---|---|
| Relative Strength Index (RSI) | 36.95 | 32.14 |
| Support Level | N/A | $2.74 |
| Resistance Level | $0.56 | $6.15 |
| Average True Range (ATR) | 0.03 | 0.39 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 15.03 | 23.93 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.